[HTML][HTML] Transcriptomics identify thrombospondin‐2 as a biomarker for NASH and advanced liver fibrosis
K Kozumi, T Kodama, H Murai, S Sakane… - Hepatology, 2021 - journals.lww.com
Conclusions Despite clear relationships between HBV RNA and HBcrAg levels and CHB
phases, these markers have limited additional value in differentiating CHB phases because
of their strong association with HBV DNA and, to a lesser extent, with clinical disease
indicators.
phases, these markers have limited additional value in differentiating CHB phases because
of their strong association with HBV DNA and, to a lesser extent, with clinical disease
indicators.